DVA News and Press, DaVita Inc. From 09/09/21

EDEN PRAIRIE, Minn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the hiring of Dr. John Barry as Vice...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the broader stock market   soars to new highs regularly, growth stocks have also regained their popularity among investors — and that has created many stocks to buy for investors. The Street seems to be de...

Berkshire Hathaway's 13F stock portfolio value increased from $270.44B to $293.02B this quarter. Their largest three holdings are at ~64% of the entire portfolio. Berkshire Hathaway increased Kroger while reducing Merck and Liberty Global during the quarter. For further deta...

DaVita recorded strong adjusted EPS growth for Q2 FY12/2021 but one-off factors were the key drivers with limited underlying growth in the business. With a highly levered balance sheet, we believe future share buybacks activity will be limited which is problematic for shareholder retu...

EDEN PRAIRIE, Minn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world, announced st...

Many investors like to turn to Warren Buffett's investing ideas for improving returns. While studying Berkshire Hathaway 's (NYSE: BRK.A) (NYSE: BRK.B) portfolio may seem prudent, investors should remember that not all of his holdings are buys at this time. Nonetheless, he a...

DaVita Inc. (DVA) Q2 2021 Earnings Conference Call August 3, 2021 5:00 PM ET Company Participants Jim Gustafson – Vice President of Investor Relations Javier Rodriguez – Chief Executive Officer Joel Ackerman – Chief Financial Officer Conference Call Participants Pito Chic...

Image source: The Motley Fool. DaVita Inc (NYSE: DVA) Q2 2021 Earnings Call Aug 3, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: DaVita Inc (DVA) Q2 2021 Earnings Call Transcript

DaVita HealthCare Partners (NYSE:DVA) posted second-quarter results that beat Wall Street estimates, and raised its profit forecast for the year. The company's quarterly revenue increased more than 1% to $2.92B, beating analysts' estimate by $50M. 2021 Guidance: Adj. EPS of $8.80-$9...

DaVita HealthCare Partners (NYSE:DVA): Q2 GAAP EPS of $2.76 beats by $0.68. Revenue of $2.92B (+1.4% Y/Y) beats by $50M. 2021 Guidance: Adj. EPS of $8.80-$9.40 from prior guidance of $8.20-$9.00 vs. $8.66 consnesus. Adj. operating income of $1.8B-$1.87B vs. $1.75B in FY20; and FCF o...